Skip to main content

Crowley Elizabeth's Form 4 filing

Celldex Therapeutics, Inc. (CLDX) · filed Jun 11, 2024

Accession no.
0001415889-24-016345
Filed
Jun 11, 2024
Trade date
Jun 7, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $525.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Crowley ElizabethCIK 0001681854Officer (SR. VP & CPDO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 7, 2024Common StockMOption exerciseAcquired+7,500$10.38+$77,85016,574Direct
Jun 7, 2024Common StockMOption exerciseAcquired+7,500$9.02+$67,65024,074Direct
Jun 7, 2024Common StockSSaleDisposed−15,000$35.06−$525,9009,074Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 7, 2024Common StockMOption exerciseDisposed−7,500$0.00$076,500Direct
Jun 7, 2024Common StockMOption exerciseDisposed−7,500$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)